These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Long-term outcome of azathioprine versus mycophenolate mofetil in cyclosporine-based immunosuppression in kidney transplantation: 10 years of experience at a single center. Kwon O; Cho JH; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD Transplant Proc; 2013 May; 45(4):1487-90. PubMed ID: 23726603 [TBL] [Abstract][Full Text] [Related]
27. Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation. Lo A; Stratta RJ; Alloway RR; Egidi MF; Shokouh-Amiri MH; Grewal HP; Gaber LW; Gaber AO Transpl Int; 2001 Dec; 14(6):396-404. PubMed ID: 11793037 [TBL] [Abstract][Full Text] [Related]
28. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis. Ciancio G; Gaynor JJ; Zarak A; Sageshima J; Guerra G; Roth D; Brown R; Kupin W; Chen L; Tueros L; Hanson L; Ruiz P; Burke GW Transplantation; 2011 Jun; 91(11):1198-205. PubMed ID: 21107305 [TBL] [Abstract][Full Text] [Related]
29. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence. Pham PT; Pham PC Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327 [TBL] [Abstract][Full Text] [Related]
31. Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients? Johnson DW; Nicol DL; Purdie DM; Preston JM; Brown AM; Hawley CM; Campbell SB; Wall D; Griffin AD; Isbel NM Transplantation; 2002 Apr; 73(7):1158-63. PubMed ID: 11965051 [TBL] [Abstract][Full Text] [Related]
32. Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil. Traitanon O; Mathew JM; Shetty A; Bontha SV; Maluf DG; El Kassis Y; Park SH; Han J; Ansari MJ; Leventhal JR; Mas V; Gallon L PLoS One; 2019; 14(5):e0216300. PubMed ID: 31136582 [TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil in low-risk renal transplantation in patients receiving no cyclosporine: a single-centre experience. Raheem OA; Daly PJ; O'Kelly P; Shields WP; Zimmerman AJ; Mohan P; Power R; Little DM; Conlon PJ; Hickey DP Nephrol Dial Transplant; 2012 Feb; 27(2):840-4. PubMed ID: 21622991 [TBL] [Abstract][Full Text] [Related]
34. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial. Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153 [TBL] [Abstract][Full Text] [Related]
35. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up. Ciancio G; Burke GW; Gaynor JJ; Roth D; Sageshima J; Kupin W; Tueros L; Hanson L; Rosen A; Ruiz P; Miller J Transplantation; 2008 Jul; 86(1):67-74. PubMed ID: 18622280 [TBL] [Abstract][Full Text] [Related]
36. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. Favi E; Spagnoletti G; Salerno MP; Pedroso JA; Romagnoli J; Citterio F Clin Transplant; 2013; 27(4):E359-67. PubMed ID: 23710603 [TBL] [Abstract][Full Text] [Related]
37. Mycophenolic acid dose reductions result in poor long-term renal allograft survival: comparison between mycophenolate sodium and mycophenolate mofetil. Laftavi MR; Hai F; Laftavi H; Feng L; Said M; Patel S; Kohli R; Alnimri M; Dayton M; Pankewycz O Transplant Proc; 2011 Mar; 43(2):478-81. PubMed ID: 21440738 [TBL] [Abstract][Full Text] [Related]
38. Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. Vacher-Coponat H; Brunet C; Moal V; Loundou A; Bonnet E; Lyonnet L; Ravet S; Sampol-Manos E; Sampol J; Berland Y; George FD; Paul P Transplantation; 2006 Aug; 82(4):558-66. PubMed ID: 16926601 [TBL] [Abstract][Full Text] [Related]
39. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy. El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298 [TBL] [Abstract][Full Text] [Related]
40. Lung Transplant Outcomes in Adults in the United States: Retrospective Cohort Study Using Real-world Evidence from the SRTR. Erdman J; Wolfram J; Nimke D; Croy R; Wang X; Weaver T; Schladt D; Fitzsimmons WE Transplantation; 2022 Jun; 106(6):1233-1242. PubMed ID: 34974456 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]